Prof. Dr. Thomas Harrer



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023) Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al. Journal article, Letter Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller (2023) El Kenz B, Schmidt K, Ogungbemi-Alt VK, Bergmann S, Steininger P, Korn K, Spriewald B, et al. Journal article Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy (2023) Fischhaber N, Schmiedeberg M, Kübel S, Harrer E, Harrer T, Nganou-Makamdop K Journal article Fatal Puumala Hantavirus Infection in a Patient with Common Variable Immunodeficiency (CVID) (2023) Steininger P, Herbst L, Bihlmaier K, Willam C, Koerper S, Schrezenmeier H, Klueter H, et al. Journal article Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. (2023) Bergmann C, Müller F, Distler J, Györfi AH, Völkl S, Aigner M, Kretschmann S, et al. Journal article, Letter Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections (2023) Schmitt C, Hoefsmit EP, Fangmeier T, Kramer N, Kabakci C, Vera González J, Versluis JM, et al. Journal article Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature (2023) Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M Journal article Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine (2023) Schmidt K, Harrer E, Schönau V, Simon D, Kleyer A, Steininger P, Korn K, et al. Journal article In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation (2023) Jensen BEO, Knops E, Cords L, Lübke N, Salgado M, Busman-Sahay K, Estes JD, et al. Journal article, Original article Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy (2022) Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Kremer A, Tenbusch M, et al. Conference contribution